List of Tables
Table 1. Meningococcal Vaccines Market Segments
Table 2. Ranking of Global Top Meningococcal Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Meningococcal Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Menactra
Table 5. Major Manufacturers of Menomune
Table 6. Global Meningococcal Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Meningococcal Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Meningococcal Vaccines Sales by Regions 2015-2020 (K Units)
Table 9. Global Meningococcal Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Meningococcal Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Meningococcal Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Meningococcal Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Meningococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Meningococcal Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccines as of 2019)
Table 15. Meningococcal Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Meningococcal Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Meningococcal Vaccines Price (2015-2020) (USD/Unit)
Table 18. Meningococcal Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Meningococcal Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Meningococcal Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 23. Global Meningococcal Vaccines Sales Share by Type (2015-2020)
Table 24. Global Meningococcal Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Meningococcal Vaccines Revenue Share by Type (2015-2020)
Table 26. Meningococcal Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 28. Global Meningococcal Vaccines Sales Share by Application (2015-2020)
Table 29. North America Meningococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 30. North America Meningococcal Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Meningococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 34. North America Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 36. North America Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Meningococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 38. Europe Meningococcal Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Meningococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 42. Europe Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 44. Europe Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Meningococcal Vaccines Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Meningococcal Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Meningococcal Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Meningococcal Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Meningococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 54. Latin America Meningococcal Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Meningococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 58. Latin America Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 60. Latin America Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Meningococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Meningococcal Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Meningococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Table 69. GlaxoSmithKline Corporation Information
Table 70. GlaxoSmithKline Description and Major Businesses
Table 71. GlaxoSmithKline Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. GlaxoSmithKline Product
Table 73. GlaxoSmithKline Recent Development
Table 74. JN-International Medical Corporation Information
Table 75. JN-International Medical Description and Major Businesses
Table 76. JN-International Medical Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. JN-International Medical Product
Table 78. JN-International Medical Recent Development
Table 79. Novartis International Corporation Information
Table 80. Novartis International Description and Major Businesses
Table 81. Novartis International Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Novartis International Product
Table 83. Novartis International Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. Baxter International Corporation Information
Table 95. Baxter International Description and Major Businesses
Table 96. Baxter International Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Baxter International Product
Table 98. Baxter International Recent Development
Table 99. Global Meningococcal Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 100. Global Meningococcal Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Meningococcal Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Meningococcal Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 104. North America: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 106. Europe: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Meningococcal Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 108. Asia Pacific: Meningococcal Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 110. Latin America: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 112. Middle East and Africa: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Meningococcal Vaccines Players
Table 117. Meningococcal Vaccines Customers List
Table 118. Meningococcal Vaccines Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningococcal Vaccines Product Picture
Figure 2. Global Meningococcal Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Menactra Product Picture
Figure 4. Menomune Product Picture
Figure 5. Global Meningococcal Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Pneumonia
Figure 7. Meningitis
Figure 8. Bacteremia
Figure 9. Others (Arthritis, Conjunctivitis, Urethritis)
Figure 10. Meningococcal Vaccines Report Years Considered
Figure 11. Global Meningococcal Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Meningococcal Vaccines Sales 2015-2026 (K Units)
Figure 13. Global Meningococcal Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Meningococcal Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Meningococcal Vaccines Sales Market Share by Region in 2019
Figure 16. Global Meningococcal Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Meningococcal Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Meningococcal Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Vaccines Revenue in 2019
Figure 20. Meningococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Meningococcal Vaccines Sales Market Share by Type in 2019
Figure 23. Global Meningococcal Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Meningococcal Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Meningococcal Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Meningococcal Vaccines Sales Market Share by Application in 2019
Figure 28. Global Meningococcal Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Meningococcal Vaccines Revenue Market Share by Application in 2019
Figure 30. North America Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Meningococcal Vaccines Sales Market Share by Country in 2019
Figure 33. North America Meningococcal Vaccines Revenue Market Share by Country in 2019
Figure 34. U.S. Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Meningococcal Vaccines Market Share by Type in 2019
Figure 39. North America Meningococcal Vaccines Market Share by Application in 2019
Figure 40. Europe Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Meningococcal Vaccines Sales Market Share by Country in 2019
Figure 43. Europe Meningococcal Vaccines Revenue Market Share by Country in 2019
Figure 44. Germany Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Meningococcal Vaccines Market Share by Type in 2019
Figure 55. Europe Meningococcal Vaccines Market Share by Application in 2019
Figure 56. Asia Pacific Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Meningococcal Vaccines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Meningococcal Vaccines Revenue Market Share by Region in 2019
Figure 60. China Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Meningococcal Vaccines Market Share by Type in 2019
Figure 83. Asia Pacific Meningococcal Vaccines Market Share by Application in 2019
Figure 84. Latin America Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Meningococcal Vaccines Sales Market Share by Country in 2019
Figure 87. Latin America Meningococcal Vaccines Revenue Market Share by Country in 2019
Figure 88. Mexico Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Meningococcal Vaccines Market Share by Type in 2019
Figure 95. Latin America Meningococcal Vaccines Market Share by Application in 2019
Figure 96. Middle East and Africa Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Meningococcal Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Meningococcal Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Meningococcal Vaccines Market Share by Type in 2019
Figure 107. Middle East and Africa Meningococcal Vaccines Market Share by Application in 2019
Figure 108. North America Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed